Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00619879 · ClinicalTrials.gov registry record
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
A clinical trial, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- 81
- Enrollment target
NCT00619879: Completed study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT00619879 is a clinical trial that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00619879 has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
The purpose of this study is to show that myeloablative hematopoietic progenitor cell transplantation (HPCT) continues to offer acceptable disease-free survival for select patients requiring HPCT.
Interventions
- DRUG Myeloablative Chemotherapy Regimen for Lymphoid Malignancies or Cord Blood Unit Recipients
- DRUG Myeloablative Chemotherapy Regimen for Non-Cord Blood Unit Recipients with Myeloid Malignancies
- OTHER Hematopoietic Progenitor Cell Transplantation (HPCT)
- RADIATION CNS radiation treatment for ALL with prior CNS disease patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2007-03-26 |
| Est. Completion | 2019-02-07 |
What the finished NCT00619879 record still lists
NCT00619879 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Myeloablative Chemotherapy Regimen for Lymphoid Malignancies or Cord Blood Unit Recipients is the first listed.
NCT00619879 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00619879 about?
NCT00619879 is a clinical study titled "Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies". The purpose of this study is to show that myeloablative hematopoietic progenitor cell transplantation (HPCT) continues to offer acceptable disease-free survival for select patients requiring HPCT.
What is the current status of trial NCT00619879?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2007-03-26. Estimated completion is 2019-02-07.
What interventions are being tested in trial NCT00619879?
The interventions under investigation include: Myeloablative Chemotherapy Regimen for Lymphoid Malignancies or Cord Blood Unit Recipients (DRUG), Myeloablative Chemotherapy Regimen for Non-Cord Blood Unit Recipients with Myeloid Malignancies (DRUG), Hematopoietic Progenitor Cell Transplantation (HPCT) (OTHER), CNS radiation treatment for ALL with prior CNS disease patients (RADIATION).
Who is sponsoring clinical trial NCT00619879?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI